Publications To Date

    NANOSTRING PUBLICATIONS

    Filter Publications

    PAGE 60 OF 78 | DISPLAYING 886 - 900 OF 1166 RESULTS

    Butowski N. et al., Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study, [Epub ahead of print]., Neuro-Oncol., Oct 08, 2015

    Liu Y. et al., ALDH1A1 mRNA expression in association with prognosis of triple-negative breast cancer., [Epub ahead of print]., Oncotarget, Oct 08, 2015

    Hingorani P. et al., Clinical Application of Prognostic Gene Expression Signature in Fusion Gene–Negative Rhabdomyosarcoma: A Report from the Children's Oncology Group., [Epub ahead of print], Clin. Cancer Res., Oct 01, 2015

    Wang W. et al., Aberrant Level of miRNAs in Bone Marrow Microenvironment and Peripheral Blood of Myeloma Patients and Disease Progression., [Epub ahead of print]., J. Mol. Diag., Sep 30, 2015

    Jones K.A. et al., Selective coexpression of VEGF receptor 2 in EGFRvIII-positive glioblastoma cells prevents cellular senescence and contributes to their aggressive nature., [Epub ahead of print]., Neuro-oncology, Sep 29, 2015

    Ortega-Molina A et al., The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development., [Epub ahead of print]., Nat. Med., Sep 14, 2015

    Spears M. et al., A four gene signature predicts benefit from anthracyclines: evidence from the BR9601 and MA.5 clinical trials., [Epub ahead of print]., Oncotarget, Sep 10, 2015

    Magbanua M.J.M. et al., Approaches to isolation and molecular characterization of disseminated tumor cells., [Epub ahead of print]., Oncotarget, Sep 10, 2015

    Quek S-I. et al., Processing of voided urine for prostate cancer RNA biomarker analysis., [Epub ahead of print]., The Prostate, Aug 26, 2015

    Kridel R. et al., Cell of origin of transformed follicular lymphoma, [Epub ahead of print]., Blood, Aug 25, 2015

    Wallden B. et al., Development and verification of the PAM50-based Prosigna breast cancer gene signature assay., , BMC Med Genomics, Aug 22, 2015

    Omuro A. et al., Phase II Study of Bevacizumab, Temozolomide and Hypofractionated Stereotactic Radiotherapy for Newly Diagnosed Glioblastoma, [Epub ahead of print]., Clin. Cancer Res., Aug 08, 2015

    Chen D.T. et al., Prognostic Fifteen-Gene Signature for Early Stage Pancreatic Ductal Adenocarcinoma., [Epub ahead of print]., PLoS ONE, Aug 06, 2015

    Scott D.W. et al., Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Biopsies., [Epub ahead of print]., J. Clin. Oncol., Aug 03, 2015

    Masque-Solar N. et al., Clinical and pathological features of Burkitt lymphoma showing expression of BCL2 - an analysis including gene expression in formalin-fixed paraffin-embedded tissue., [Epub ahead of print]., Br. J. Haematol., Jul 27, 2015